-
1
-
-
79953320228
-
New strategies in metastatic prostate cancer: Targeting the androgen receptor signaling pathway
-
Attard, G.; Richards, J.; de Bono, J. S. New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway Clin. Cancer Res. 2011, 17, 1649-1657
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 1649-1657
-
-
Attard, G.1
Richards, J.2
De Bono, J.S.3
-
2
-
-
84870591476
-
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
-
Decker, K. F.; Zheng, D.; He, Y.; Bowman, T.; Edwards, J. R.; Jia, L. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions Nucleic Acids Res. 2012, 40, 10765-10779
-
(2012)
Nucleic Acids Res.
, vol.40
, pp. 10765-10779
-
-
Decker, K.F.1
Zheng, D.2
He, Y.3
Bowman, T.4
Edwards, J.R.5
Jia, L.6
-
3
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
de Bono, J. S.; Logothetis, C. J.; Molina, A.; Fizazi, K.; North, S.; Chu, L.; Chi, K. N.; Jones, R. J.; Goodman, O. B., Jr.; Saad, F.; Staffurth, J. N.; Mainwaring, P.; Harland, S.; Flaig, T. W.; Hutson, T. E.; Cheng, T.; Patterson, H.; Hainsworth, J. D.; Ryan, C. J.; Sternberg, C. N.; Ellard, S. L.; Flechon, A.; Saleh, M.; Scholz, M.; Efstathiou, E.; Zivi, A.; Bianchini, D.; Loriot, Y.; Chieffo, N.; Kheoh, T.; Haqq, C. M.; Scher, H. I. Abiraterone and increased survival in metastatic prostate cancer N. Engl. J. Med. 2011, 364, 1995-2005
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
Fizazi, K.4
North, S.5
Chu, L.6
Chi, K.N.7
Jones, R.J.8
Goodman Jr., O.B.9
Saad, F.10
Staffurth, J.N.11
Mainwaring, P.12
Harland, S.13
Flaig, T.W.14
Hutson, T.E.15
Cheng, T.16
Patterson, H.17
Hainsworth, J.D.18
Ryan, C.J.19
Sternberg, C.N.20
Ellard, S.L.21
Flechon, A.22
Saleh, M.23
Scholz, M.24
Efstathiou, E.25
Zivi, A.26
Bianchini, D.27
Loriot, Y.28
Chieffo, N.29
Kheoh, T.30
Haqq, C.M.31
Scher, H.I.32
more..
-
4
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
Scher, H. I.; Fizazi, K.; Saad, F.; Taplin, M. E.; Sternberg, C. N.; Miller, K.; de Wit, R.; Mulders, P.; Chi, K. N.; Shore, N. D.; Armstrong, A. J.; Flaig, T. W.; Flechon, A.; Mainwaring, P.; Fleming, M.; Hainsworth, J. D.; Hirmand, M.; Selby, B.; Seely, L.; de Bono, J. S. Increased survival with enzalutamide in prostate cancer after chemotherapy N. Engl. J. Med. 2012, 367, 1187-1197
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
Taplin, M.E.4
Sternberg, C.N.5
Miller, K.6
De Wit, R.7
Mulders, P.8
Chi, K.N.9
Shore, N.D.10
Armstrong, A.J.11
Flaig, T.W.12
Flechon, A.13
Mainwaring, P.14
Fleming, M.15
Hainsworth, J.D.16
Hirmand, M.17
Selby, B.18
Seely, L.19
De Bono, J.S.20
more..
-
5
-
-
84875150133
-
Enzalutamide: A novel anti-androgen for patients with castrate resistant prostate cancer
-
Hoffman-Censits, J.; Kelly, W. K. Enzalutamide: a novel anti-androgen for patients with castrate resistant prostate cancer Clin. Cancer Res. 2013, 19, 1335-1339
-
(2013)
Clin. Cancer Res.
, vol.19
, pp. 1335-1339
-
-
Hoffman-Censits, J.1
Kelly, W.K.2
-
6
-
-
17844376217
-
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
-
Bohl, C. E.; Gao, W.; Miller, D. D.; Bell, C. E.; Dalton, J. T. Structural basis for antagonism and resistance of bicalutamide in prostate cancer Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 6201-6206
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 6201-6206
-
-
Bohl, C.E.1
Gao, W.2
Miller, D.D.3
Bell, C.E.4
Dalton, J.T.5
-
7
-
-
27844611242
-
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor
-
Bohl, C. E.; Miller, D. D.; Chen, J.; Bell, C. E.; Dalton, J. T. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor J. Biol. Chem. 2005, 280, 37747-37754
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 37747-37754
-
-
Bohl, C.E.1
Miller, D.D.2
Chen, J.3
Bell, C.E.4
Dalton, J.T.5
-
8
-
-
84879067087
-
Overcoming mutation-based resistance to antiandrogens with rational drug design
-
Balbas, M. D.; Evans, M. J.; Hosfield, D. J.; Wongvipat, J.; Arora, V. K.; Watson, P. A.; Chen, Y.; Greene, G. L.; Shen, Y.; Sawyers, C. L. Overcoming mutation-based resistance to antiandrogens with rational drug design Elife 2013, 2, e00499
-
(2013)
Elife
, vol.2
, pp. 00499
-
-
Balbas, M.D.1
Evans, M.J.2
Hosfield, D.J.3
Wongvipat, J.4
Arora, V.K.5
Watson, P.A.6
Chen, Y.7
Greene, G.L.8
Shen, Y.9
Sawyers, C.L.10
-
9
-
-
77952105685
-
Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study
-
Scher, H. I.; Beer, T. M.; Higano, C. S.; Anand, A.; Taplin, M. E.; Efstathiou, E.; Rathkopf, D.; Shelkey, J.; Yu, E. Y.; Alumkal, J.; Hung, D.; Hirmand, M.; Seely, L.; Morris, M. J.; Danila, D. C.; Humm, J.; Larson, S.; Fleisher, M.; Sawyers, C. L. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study Lancet 2010, 375, 1437-1446
-
(2010)
Lancet
, vol.375
, pp. 1437-1446
-
-
Scher, H.I.1
Beer, T.M.2
Higano, C.S.3
Anand, A.4
Taplin, M.E.5
Efstathiou, E.6
Rathkopf, D.7
Shelkey, J.8
Yu, E.Y.9
Alumkal, J.10
Hung, D.11
Hirmand, M.12
Seely, L.13
Morris, M.J.14
Danila, D.C.15
Humm, J.16
Larson, S.17
Fleisher, M.18
Sawyers, C.L.19
-
10
-
-
84872534568
-
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
-
Li, Y.; Chan, S. C.; Brand, L. J.; Hwang, T. H.; Silverstein, K. A.; Dehm, S. M. Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines Cancer Res. 2012, 73, 483-489
-
(2012)
Cancer Res.
, vol.73
, pp. 483-489
-
-
Li, Y.1
Chan, S.C.2
Brand, L.J.3
Hwang, T.H.4
Silverstein, K.A.5
Dehm, S.M.6
-
11
-
-
78049280194
-
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
-
Watson, P. A.; Chen, Y. F.; Balbas, M. D.; Wongvipat, J.; Socci, N. D.; Viale, A.; Kim, K.; Sawyers, C. L. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 16759-16765
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 16759-16765
-
-
Watson, P.A.1
Chen, Y.F.2
Balbas, M.D.3
Wongvipat, J.4
Socci, N.D.5
Viale, A.6
Kim, K.7
Sawyers, C.L.8
-
12
-
-
80054931284
-
Alternatively spliced androgen receptor variants
-
Dehm, S. M.; Tindall, D. J. Alternatively spliced androgen receptor variants Endocr.-Relat. Cancer 2011, 18, R183-R196
-
(2011)
Endocr.-Relat. Cancer
, vol.18
-
-
Dehm, S.M.1
Tindall, D.J.2
-
13
-
-
79952772097
-
Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression
-
Li, Y.; Alsagabi, M.; Fan, D.; Bova, G. S.; Tewfik, A. H.; Dehm, S. M. Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression Cancer Res. 2011, 71, 2108-2117
-
(2011)
Cancer Res.
, vol.71
, pp. 2108-2117
-
-
Li, Y.1
Alsagabi, M.2
Fan, D.3
Bova, G.S.4
Tewfik, A.H.5
Dehm, S.M.6
-
14
-
-
84861728843
-
Androgen receptor splice variants activate AR target genes and support aberrant prostate cancer cell growth independent of the canonical AR nuclear localization signal
-
Chan, S. C.; Li, Y.; Dehm, S. M. Androgen receptor splice variants activate AR target genes and support aberrant prostate cancer cell growth independent of the canonical AR nuclear localization signal J. Biol. Chem. 2012, 23, 19736-19749
-
(2012)
J. Biol. Chem.
, vol.23
, pp. 19736-19749
-
-
Chan, S.C.1
Li, Y.2
Dehm, S.M.3
-
15
-
-
84863979005
-
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
-
Hu, R.; Lu, C. X.; Mostaghel, E. A.; Yegnasubramanian, S.; Gurel, M.; Tannahill, C.; Edwards, J.; Isaacs, W. B.; Nelson, P. S.; Bluemn, E.; Plymate, S. R.; Luo, J. Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer Cancer Res. 2012, 72, 3457-3462
-
(2012)
Cancer Res.
, vol.72
, pp. 3457-3462
-
-
Hu, R.1
Lu, C.X.2
Mostaghel, E.A.3
Yegnasubramanian, S.4
Gurel, M.5
Tannahill, C.6
Edwards, J.7
Isaacs, W.B.8
Nelson, P.S.9
Bluemn, E.10
Plymate, S.R.11
Luo, J.12
-
16
-
-
84863111874
-
Stepwise androgen receptor dimerization
-
van Royen, M. E.; van Cappellen, W. A.; de Vos, C.; Houtsmuller, A. B.; Trapman, J. Stepwise androgen receptor dimerization J. Cell Sci. 2012, 125, 1970-1979
-
(2012)
J. Cell Sci.
, vol.125
, pp. 1970-1979
-
-
Van Royen, M.E.1
Van Cappellen, W.A.2
De Vos, C.3
Houtsmuller, A.B.4
Trapman, J.5
-
17
-
-
0025780755
-
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
-
Luisi, B. F.; Xu, W. X.; Otwinowski, Z.; Freedman, L. P.; Yamamoto, K. R.; Sigler, P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature 1991, 352, 497-505
-
(1991)
Nature
, vol.352
, pp. 497-505
-
-
Luisi, B.F.1
Xu, W.X.2
Otwinowski, Z.3
Freedman, L.P.4
Yamamoto, K.R.5
Sigler, P.B.6
-
18
-
-
0027365669
-
The Crystal-Structure of the Estrogen-Receptor DNA-Binding Domain Bound to DNA-How Receptors Discriminate between Their Response Elements
-
Schwabe, J. W. R.; Chapman, L.; Finch, J. T.; Rhodes, D. The Crystal-Structure of the Estrogen-Receptor DNA-Binding Domain Bound to DNA-How Receptors Discriminate between Their Response Elements Cell 1993, 75, 567-578
-
(1993)
Cell
, vol.75
, pp. 567-578
-
-
Schwabe, J.W.R.1
Chapman, L.2
Finch, J.T.3
Rhodes, D.4
-
19
-
-
1842637389
-
Structural basis of androgen receptor binding to selective androgen response elements
-
Shaffer, P. L.; Jivan, A.; Dollins, D. E.; Claessens, F.; Gewirth, D. T. Structural basis of androgen receptor binding to selective androgen response elements Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 4758-4763
-
(2004)
Proc. Natl. Acad. Sci. U. S. A.
, vol.101
, pp. 4758-4763
-
-
Shaffer, P.L.1
Jivan, A.2
Dollins, D.E.3
Claessens, F.4
Gewirth, D.T.5
-
20
-
-
33751551165
-
Structure of the progesterone receptor-deoxyribonucleic acid complex: Novel interactions required for binding to half-site response elements
-
Roemer, S. C.; Donham, D. C.; Sherman, L.; Pon, V. H.; Edwards, D. P.; Churchill, M. E. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements Mol. Endocrinol. 2006, 20, 3042-3052
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 3042-3052
-
-
Roemer, S.C.1
Donham, D.C.2
Sherman, L.3
Pon, V.H.4
Edwards, D.P.5
Churchill, M.E.6
-
21
-
-
0035369335
-
Nuclear-receptor interactions on DNA-response elements
-
Khorasanizadeh, S.; Rastinejad, F. Nuclear-receptor interactions on DNA-response elements Trends Biochem. Sci. 2001, 26, 384-390
-
(2001)
Trends Biochem. Sci.
, vol.26
, pp. 384-390
-
-
Khorasanizadeh, S.1
Rastinejad, F.2
-
22
-
-
34547496561
-
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide
-
Nickols, N. G.; Dervan, P. B. Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 10418-10423
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 10418-10423
-
-
Nickols, N.G.1
Dervan, P.B.2
-
23
-
-
66349124428
-
Non-competitive androgen receptor inhibition in vitro and in vivo
-
Jones, J. O.; Bolton, E. C.; Huang, Y.; Feau, C.; Guy, R. K.; Yamamoto, K. R.; Hann, B.; Diamond, M. I. Non-competitive androgen receptor inhibition in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 7233-7238
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 7233-7238
-
-
Jones, J.O.1
Bolton, E.C.2
Huang, Y.3
Feau, C.4
Guy, R.K.5
Yamamoto, K.R.6
Hann, B.7
Diamond, M.I.8
-
24
-
-
0031687653
-
Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design
-
Liang, J.; Edelsbrunner, H.; Woodward, C. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design Protein Sci. 1998, 7, 1884-1897
-
(1998)
Protein Sci.
, vol.7
, pp. 1884-1897
-
-
Liang, J.1
Edelsbrunner, H.2
Woodward, C.3
-
25
-
-
13844312649
-
ZINC-a free database of commercially available compounds for virtual screening
-
Irwin, J. J.; Shoichet, B. K. ZINC-a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182
-
(2005)
J. Chem. Inf. Model.
, vol.45
, pp. 177-182
-
-
Irwin, J.J.1
Shoichet, B.K.2
-
26
-
-
33847382319
-
Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells
-
Tavassoli, P.; Snoek, R.; Ray, M.; Rao, L. G.; Rennie, P. S. Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells Prostate 2007, 67, 416-426
-
(2007)
Prostate
, vol.67
, pp. 416-426
-
-
Tavassoli, P.1
Snoek, R.2
Ray, M.3
Rao, L.G.4
Rennie, P.S.5
-
27
-
-
84894024670
-
Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
-
Zhuang, C.; Narayanapillai, S.; Zhang, W.; Sham, Y. Y.; Xing, C. Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search J. Med. Chem. 2014, 57 (3) 1121-1126
-
(2014)
J. Med. Chem.
, vol.57
, Issue.3
, pp. 1121-1126
-
-
Zhuang, C.1
Narayanapillai, S.2
Zhang, W.3
Sham, Y.Y.4
Xing, C.5
-
28
-
-
84877686260
-
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo
-
Kuruma, H.; Matsumoto, H.; Shiota, M.; Bishop, J.; Lamoureux, F.; Thomas, C.; Briere, D.; Los, G.; Gleave, M.; Fanjul, A.; Zoubeidi, A. A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo Mol. Cancer Ther. 2013, 12, 567-576
-
(2013)
Mol. Cancer Ther.
, vol.12
, pp. 567-576
-
-
Kuruma, H.1
Matsumoto, H.2
Shiota, M.3
Bishop, J.4
Lamoureux, F.5
Thomas, C.6
Briere, D.7
Los, G.8
Gleave, M.9
Fanjul, A.10
Zoubeidi, A.11
-
29
-
-
0031838203
-
Differential transactivation by the androgen receptor in prostate cancer cells
-
Snoek, R.; Bruchovsky, N.; Kasper, S.; Matusik, R. J.; Gleave, M.; Sato, N.; Mawji, N. R.; Rennie, P. S. Differential transactivation by the androgen receptor in prostate cancer cells Prostate 1998, 36, 256-263
-
(1998)
Prostate
, vol.36
, pp. 256-263
-
-
Snoek, R.1
Bruchovsky, N.2
Kasper, S.3
Matusik, R.J.4
Gleave, M.5
Sato, N.6
Mawji, N.R.7
Rennie, P.S.8
-
30
-
-
85029569102
-
-
Dalal, K.; Moniri, M.; Sharma, A.; Li, H.; Ban, F.; Hessein, M.; Hsing, M.; Singh, K.; Leblanc, E.; Dehm, S.; Guns, E. T.; Cherkasov, A.; Rennie, P. S. Selectively Targeting the DNA Binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer 2014.
-
(2014)
Selectively Targeting the DNA Binding Domain of the Androgen Receptor As A Prospective Therapy for Prostate Cancer
-
-
Dalal, K.1
Moniri, M.2
Sharma, A.3
Li, H.4
Ban, F.5
Hessein, M.6
Hsing, M.7
Singh, K.8
Leblanc, E.9
Dehm, S.10
Guns, E.T.11
Cherkasov, A.12
Rennie, P.S.13
-
31
-
-
80052819425
-
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening
-
Axerio-Cilies, P.; Lack, N. A.; Nayana, M. R.; Chan, K. H.; Yeung, A.; Leblanc, E.; Guns, E. S.; Rennie, P. S.; Cherkasov, A. Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening J. Med. Chem. 2011, 54, 6197-6205
-
(2011)
J. Med. Chem.
, vol.54
, pp. 6197-6205
-
-
Axerio-Cilies, P.1
Lack, N.A.2
Nayana, M.R.3
Chan, K.H.4
Yeung, A.5
Leblanc, E.6
Guns, E.S.7
Rennie, P.S.8
Cherkasov, A.9
-
32
-
-
35348812462
-
A surface on the androgen receptor that allosterically regulates coactivator binding
-
Estebanez-Perpina, E.; Arnold, A. A.; Nguyen, P.; Rodrigues, E. D.; Mar, E.; Bateman, R.; Pallai, P.; Shokat, K. M.; Baxter, J. D.; Guy, R. K.; Webb, P.; Fletterick, R. J. A surface on the androgen receptor that allosterically regulates coactivator binding Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 16074-16079
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 16074-16079
-
-
Estebanez-Perpina, E.1
Arnold, A.A.2
Nguyen, P.3
Rodrigues, E.D.4
Mar, E.5
Bateman, R.6
Pallai, P.7
Shokat, K.M.8
Baxter, J.D.9
Guy, R.K.10
Webb, P.11
Fletterick, R.J.12
-
33
-
-
84873912697
-
Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl)thio)-1 H-benzimidazole Derivatives
-
Munuganti, R. S.; Leblanc, E.; Axerio-Cilies, P.; Labriere, C.; Frewin, K.; Singh, K.; Hassona, M. D.; Lack, N. A.; Li, H.; Ban, F.; Tomlinson Guns, E.; Young, R.; Rennie, P. S.; Cherkasov, A. Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl)thio)-1 H-benzimidazole Derivatives J. Med. Chem. 2013, 56, 1136-1148
-
(2013)
J. Med. Chem.
, vol.56
, pp. 1136-1148
-
-
Munuganti, R.S.1
Leblanc, E.2
Axerio-Cilies, P.3
Labriere, C.4
Frewin, K.5
Singh, K.6
Hassona, M.D.7
Lack, N.A.8
Li, H.9
Ban, F.10
Tomlinson Guns, E.11
Young, R.12
Rennie, P.S.13
Cherkasov, A.14
-
34
-
-
84055217577
-
Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening
-
Lack, N. A.; Axerio-Cilies, P.; Tavassoli, P.; Han, F. Q.; Chan, K. H.; Feau, C.; Leblanc, E.; Guns, E. T.; Guy, R. K.; Rennie, P. S.; Cherkasov, A. Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening J. Med. Chem. 2011, 54, 8563-8573
-
(2011)
J. Med. Chem.
, vol.54
, pp. 8563-8573
-
-
Lack, N.A.1
Axerio-Cilies, P.2
Tavassoli, P.3
Han, F.Q.4
Chan, K.H.5
Feau, C.6
Leblanc, E.7
Guns, E.T.8
Guy, R.K.9
Rennie, P.S.10
Cherkasov, A.11
-
35
-
-
84863115562
-
"true" Antiandrogens-Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor-Coactivator Interactions: Novel Tools for Prostate Cancer
-
Caboni, L.; Kinsella, G. K.; Blanco, F.; Fayne, D.; Jagoe, W. N.; Carr, M.; Williams, D. C.; Meegan, M. J.; Lloyd, D. G. "True" Antiandrogens-Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor-Coactivator Interactions: Novel Tools for Prostate Cancer J. Med. Chem. 2012, 55, 1635-1644
-
(2012)
J. Med. Chem.
, vol.55
, pp. 1635-1644
-
-
Caboni, L.1
Kinsella, G.K.2
Blanco, F.3
Fayne, D.4
Jagoe, W.N.5
Carr, M.6
Williams, D.C.7
Meegan, M.J.8
Lloyd, D.G.9
-
36
-
-
84887454928
-
Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer
-
Li, H.; Hassona, M. D.; Lack, N. A.; Axerio-Cilies, P.; Leblanc, E.; Tavassoli, P.; Kanaan, N.; Frewin, K.; Singh, K.; Adomat, H.; Bohm, K. J.; Prinz, H.; Guns, E. T.; Rennie, P. S.; Cherkasov, A. Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer Mol. Cancer Ther. 2013, 12, 2425-2435
-
(2013)
Mol. Cancer Ther.
, vol.12
, pp. 2425-2435
-
-
Li, H.1
Hassona, M.D.2
Lack, N.A.3
Axerio-Cilies, P.4
Leblanc, E.5
Tavassoli, P.6
Kanaan, N.7
Frewin, K.8
Singh, K.9
Adomat, H.10
Bohm, K.J.11
Prinz, H.12
Guns, E.T.13
Rennie, P.S.14
Cherkasov, A.15
-
37
-
-
84873040206
-
Identification of novel androgen receptor antagonists using structure-and ligand-based methods
-
Li, H.; Ren, X.; Leblanc, E.; Frewin, K.; Rennie, P. S.; Cherkasov, A. Identification of novel androgen receptor antagonists using structure-and ligand-based methods J. Chem. Inf. Model. 2013, 53, 123-130
-
(2013)
J. Chem. Inf. Model.
, vol.53
, pp. 123-130
-
-
Li, H.1
Ren, X.2
Leblanc, E.3
Frewin, K.4
Rennie, P.S.5
Cherkasov, A.6
-
38
-
-
84896974375
-
Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium
-
Lim, M.; Otto-Duessel, M.; He, M.; Su, L.; Nguyen, D.; Chin, E.; Alliston, T.; Jones, J. O. Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium ACS Chem. Biol. 2013, 9, 692-702
-
(2013)
ACS Chem. Biol.
, vol.9
, pp. 692-702
-
-
Lim, M.1
Otto-Duessel, M.2
He, M.3
Su, L.4
Nguyen, D.5
Chin, E.6
Alliston, T.7
Jones, J.O.8
-
39
-
-
0028927662
-
Structural determinants of DNA-binding specificity by steroid receptors
-
Zilliacus, J.; Wright, A. P.; Carlstedt-Duke, J.; Gustafsson, J. A. Structural determinants of DNA-binding specificity by steroid receptors Mol. Endocrinol. 1995, 9, 389-400
-
(1995)
Mol. Endocrinol.
, vol.9
, pp. 389-400
-
-
Zilliacus, J.1
Wright, A.P.2
Carlstedt-Duke, J.3
Gustafsson, J.A.4
-
40
-
-
0029778413
-
The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors
-
Claessens, F.; Alen, P.; Devos, A.; Peeters, B.; Verhoeven, G.; Rombauts, W. The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors J. Biol. Chem. 1996, 271, 19013-19016
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 19013-19016
-
-
Claessens, F.1
Alen, P.2
Devos, A.3
Peeters, B.4
Verhoeven, G.5
Rombauts, W.6
-
41
-
-
77953027535
-
The rules of DNA recognition by the androgen receptor
-
Denayer, S.; Helsen, C.; Thorrez, L.; Haelens, A.; Claessens, F. The rules of DNA recognition by the androgen receptor Mol. Endocrinol. 2010, 24, 898-913
-
(2010)
Mol. Endocrinol.
, vol.24
, pp. 898-913
-
-
Denayer, S.1
Helsen, C.2
Thorrez, L.3
Haelens, A.4
Claessens, F.5
-
42
-
-
12144289984
-
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
-
Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 2004, 47, 1739-1749
-
(2004)
J. Med. Chem.
, vol.47
, pp. 1739-1749
-
-
Friesner, R.A.1
Banks, J.L.2
Murphy, R.B.3
Halgren, T.A.4
Klicic, J.J.5
Mainz, D.T.6
Repasky, M.P.7
Knoll, E.H.8
Shelley, M.9
Perry, J.K.10
Shaw, D.E.11
Francis, P.12
Shenkin, P.S.13
-
43
-
-
70350409235
-
The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design?
-
Ritchie, T. J.; Macdonald, S. J. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discovery Today 2009, 14, 1011-1020
-
(2009)
Drug Discovery Today
, vol.14
, pp. 1011-1020
-
-
Ritchie, T.J.1
Macdonald, S.J.2
-
44
-
-
0031024171
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46, 3-26
-
(2001)
Adv. Drug Delivery Rev.
, vol.46
, pp. 3-26
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
45
-
-
84055217577
-
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening
-
Lack, N. A.; Axerio-Cilies, P.; Tavassoli, P.; Han, F. Q.; Chan, K. H.; Feau, C.; Leblanc, E.; Guns, E. T.; Guy, R. K.; Rennie, P. S.; Cherkasov, A. Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening J. Med. Chem. 2011, 55, 8563-8573
-
(2011)
J. Med. Chem.
, vol.55
, pp. 8563-8573
-
-
Lack, N.A.1
Axerio-Cilies, P.2
Tavassoli, P.3
Han, F.Q.4
Chan, K.H.5
Feau, C.6
Leblanc, E.7
Guns, E.T.8
Guy, R.K.9
Rennie, P.S.10
Cherkasov, A.11
|